Citadel Advisors’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-2,200
Closed -$44K 9625
2015
Q3
$44K Sell
2,200
-3,500
-61% -$70K ﹤0.01% 7676
2015
Q2
$110K Buy
5,700
+4,800
+533% +$99.4K ﹤0.01% 6994
2015
Q1
$20K Buy
900
+600
+200% +$13.8K ﹤0.01% 7923
2014
Q4
$6K Sell
300
-1,100
-79% -$23.4K ﹤0.01% 8257
2014
Q3
$28K Sell
1,400
-800
-36% -$17.4K ﹤0.01% 7265
2014
Q2
$48K Buy
2,200
+1,900
+633% +$40.4K ﹤0.01% 6774
2014
Q1
$6K Sell
300
-200
-40% -$3.94K ﹤0.01% 7633
2013
Q4
$9K Buy
500
+300
+150% +$5.69K ﹤0.01% 6742
2013
Q3
$4K Sell
200
-600
-75% -$11.8K ﹤0.01% 6613
2013
Q2
$16K Buy
+800
New +$17.3K ﹤0.01% 6129

Other funds holding BMR

Citadel Advisors's BMR Position: Q1 2016 in Review

Citadel Advisors sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 4,149 shares — an estimated $98K sold.

Citadel Advisors first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $9.22M in Q4 2014. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Citadel Advisors reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Citadel Advisors sold 4,149 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $98K.
  • Citadel Advisors first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Citadel Advisors's BIOMED REALTY TRUST INC position peaked at $9.22M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.